Osteoporosis in lung transplantation candidates with end-stage pulmonary disease

作者: Elizabeth Shane , Shonni J Silverberg , Daniel Donovan , Anastasio Papadopoulos , Ronald B Staron

DOI: 10.1016/S0002-9343(96)00155-6

关键词:

摘要: purpose Fractures, a common complication of cardiac and liver transplantation, have not been reported in association with lung transplantation. However, many patients end-stage pulmonary disease multiple risk factors for osteoporosis, several studies suggested that osteoporosis before transplantation may increase the fracture after Therefore, we evaluated group who were awaiting to determine prevalence osteoporosis. methods Seventy (aged 18–70 years) consecutively bone densitometry by dual-energy x-ray absorptiometry. The predominantly Caucasian (96%). Bone mass was expressed as mineral density (BMD; g/cm 2 ), number standard deviations (SD) below peak (T score), apparent (BMAD; 3 measurement minimizes effects size on BMD. Spine radiographs obtained subset 50 consecutive detect vertebral compression fractures. Vitamin D status assessed serum concentrations 25-hydroxyvitamin D. sorted into groups diagnosis: chronic obstructive (COPD; n=28); cystic fibrosis (n = 11); idiopathic fibrosis; other diseases (Other; n=31). results: In whole, score −2.5) present 30% at lumbar spine 49% femoral neck. Osteopenia between −1 an additional 35% 31% average neck T COPD fell osteoporotic range (−2.7 ± 0.3 −2.6 0.3, respectively), significantly ( P 0.008). Other glucocorticoids had mild osteopenia (0.972 0.06 ; T=−1.2 0.6). Very few any regimen prevent conclusions Osteoporosis vitamin deficiency are extremely disease. Only 34% normal BMD only 22% hip. Patients glucocorticoid-treated most severely affected. Therapies loss treat established uncommonly utilized Candidates should be time acceptance transplant waiting list.

参考文章(44)
L. Schwerman, M. K. Porayko, E. R. Dickson, R. A. F. Krom, S. Beaver, R. H. Wiesner, J. E. Hay, Bone disease in liver transplant recipients: incidence, timing, and risk factors. International congress of the transplantation society. ,vol. 23, pp. 1462- 1465 ,(1991)
Eisman Ja, Spratt P, Keogh Am, Freund J, Sambrook Pn, Macdonald P, Kelly Pj, Bone loss after heart transplantation: a prospective study. Journal of Heart and Lung Transplantation. ,vol. 13, pp. 116- 121 ,(1994)
M S LeBoff, G H Mudge, G M Rich, G L Laffel, Cyclosporine A and prednisone-associated osteoporosis in heart transplant recipients. Journal of Heart and Lung Transplantation. ,vol. 11, pp. 950- 958 ,(1992)
Laura K. Bachrach, Robert Marcus, Richard B. Moss, Jean Lim, Grace S. Bhudhikanok, Ann Harkins, Correlates of Osteopenia in Patients With Cystic Fibrosis Pediatrics. ,vol. 97, pp. 103- 111 ,(1996)
C M Gundberg, P S Wilson, P M Gallop, A M Parfitt, Determination of osteocalcin in human serum: results with two kits compared with those by a well-characterized assay. Clinical Chemistry. ,vol. 31, pp. 1720- 1723 ,(1985) , 10.1093/CLINCHEM/31.10.1720
Barbara P. Lukert, Bruce E. Johnson, Ralph G. Robinson, Estrogen and progesterone replacement therapy reduces glucocorticoid-induced bone loss Journal of Bone and Mineral Research. ,vol. 7, pp. 1063- 1069 ,(2009) , 10.1002/JBMR.5650070909
Barbara P. Lukert, Glucocorticoid-Induced Osteoporosis: Pathogenesis and Management Annals of Internal Medicine. ,vol. 112, pp. 352- 364 ,(1990) , 10.7326/0003-4819-112-5-352
Etienne Meys, Elizabeth Fontanges, Nicole Fourcade, Annick Thomasson, Michel Pouyet, Pierre D. Delmas, Bone loss after orthotopic liver transplantation The American Journal of Medicine. ,vol. 97, pp. 445- 450 ,(1994) , 10.1016/0002-9343(94)90324-7
Richard Eastell, E. Rolland Dickson, Stephen F. Hodgson, Russell H. Wiesner, Michael K. Porayko, Heinz W. Wahner, Sandra L. Cedel, B. Lawrence Riggs, Ruud A. F. Krom, Rates of vertebral bone loss before and after liver transplantation in women with primary biliary cirrhosis Hepatology. ,vol. 14, pp. 296- 300 ,(1991) , 10.1002/HEP.1840140215
Theodore J. Hahn, Arthur E. Squires, Linda R. Halstead, Donald B. Strominger, Reduced serum 25-hydroxyvitamin D concentration and disordered mineral metabolism in patients with cystic fibrosis. The Journal of Pediatrics. ,vol. 94, pp. 38- 42 ,(1979) , 10.1016/S0022-3476(79)80346-7